Edition:
United Kingdom

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

461.00INR
11:20am BST
Change (% chg)

Rs-8.35 (-1.78%)
Prev Close
Rs469.35
Open
Rs465.25
Day's High
Rs474.60
Day's Low
Rs459.50
Volume
5,244,937
Avg. Vol
8,995,172
52-wk High
Rs679.30
52-wk Low
Rs370.20

Latest Key Developments (Source: Significant Developments)

Sun Pharmaceutical Industries Says U.S. FDA Conducted Pre-Approval Inspection Of Co's Baska Facility
Monday, 25 Mar 2019 

March 25 (Reuters) - Sun Pharmaceutical Industries Ltd ::U.S. FDA CONDUCTED PRE-APPROVAL INSPECTION OF CO'S BASKA FACILITY (GUJARAT) FROM JANUARY 28 TO FEBRUARY 5, 2019.U.S. FDA ISSUED FORM 483, WITH ONE OBSERVATIO‍​N.  Full Article

Sun Pharmaceutical Industries Exec Says Received Query From SEBI For 2004 FCCBs Issuance, Deals With Aditya Medisales
Tuesday, 12 Feb 2019 

Feb 12 (Reuters) - Sun Pharmaceutical Industries Ltd MD Dilip Shanghvi::SUN PHARMACEUTICAL INDUSTRIES EXEC SAYS DON'T HAVE INFO ON WHISTLEBLOWER COMPLAINTS.SUN PHARMACEUTICAL INDUSTRIES EXEC SAYS RECEIVED QUERY FROM SEBI FOR 2004 FCCBS ISSUANCE, DEALS WITH ADITYA MEDISALES.SUN PHARMACEUTICAL INDUSTRIES EXEC SAYS DECIDED NOT TO LAUNCH ELEPSIA IN THE U.S..  Full Article

India's Sun Pharmaceutical Industries Dec-Qtr Consol Net Profit Surges 286.2 Pct
Tuesday, 12 Feb 2019 

Feb 12 (Reuters) - Sun Pharmaceutical Industries Ltd ::DEC QUARTER CONSOL NET PROFIT 12.42 BILLION RUPEES VERSUS PROFIT OF 3.22 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR DEC QUARTER CONSOL PROFIT WAS 9.86 BILLION RUPEES.DEC QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 77.40 BILLION RUPEES VERSUS 66.53 BILLION RUPEES LAST YEAR.  Full Article

Sun Pharma Makes Unit Distributor Of Domestic Formulations Business
Tuesday, 22 Jan 2019 

Jan 22 (Reuters) - Sun Pharmaceutical Industries Ltd ::DISTRIBUTION RELATED TO INDIA DOMESTIC FORMULATIONS BUSINESS TO BE TRANSITIONED FROM ADITYA MEDISALES TO A UNIT OF CO.TRANSITION WILL BE MADE EFFECTIVE BY Q1FY20.CONFIRMS THAT NEITHER ANY LOANS NOR GUARANTEES HAVE BEEN GIVEN TO SURAKSHA REALTY.DOES NOT HAVE ANY FINANCIAL TRANSACTIONS WITH SURAKSHA REALTY.INITIATED STEPS TO INDUCT S R B C & CO LLP AS AUDITORS OF SUBSIDIARIES THAT ARE CURRENTLY AUDITED BY VALIA & TIMBADIA..SUPPLY CONTRACT PARTIES AGREED THAT ATLAS WILL ASSIGN ITS RIGHTS, OBLIGATIONS FROM CONTRACT, TO CO'S UNIT.ASSIGNMENT WILL ENSURE THAT THE LOANS & ADVANCES GIVEN TO ATLAS WILL BE SETTLED.  Full Article

Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall Of Vecuronium Bromide For Injection
Tuesday, 8 Jan 2019 

Jan 8 (Reuters) - Sun Pharmaceutical Industries Ltd ::SUN PHARMACEUTICAL INDUSTRIES, INC. ISSUES VOLUNTARY NATIONWIDE RECALL OF VECURONIUM BROMIDE FOR INJECTION DUE TO THE PRESENCE OF PARTICULATE MATTER IDENTIFIED AS GLASS.SUN PHARMACEUTICAL-RECALLING THREE LOTS OF VECURONIUM BROMIDE FOR INJECTION 10 MG, ONE LOT OF VECURONIUM BROMIDE FOR INJECTION 20 MG TO HOSPITAL LEVEL.SUN PHARMACEUTICAL INDUSTRIES - TO DATE, SPII HAS NOT RECEIVED ANY REPORTS OF ADVERSE EVENTS RELATED TO THIS RECALL.  Full Article

Sun Pharmaceutical Industries' Unit Dusa Gets Preliminary Injunctive Relief Prohibiting Biofrontera From Using Its Trade Secrets
Wednesday, 26 Dec 2018 

Dec 26 (Reuters) - Sun Pharmaceutical Industries Ltd ::UNIT DUSA PHARMACEUTICALS AWARDED PRELIMINARY INJUNCTIVE RELIEF PROHIBITING BIOFRONTERA FROM USING ITS TRADE SECRETS.  Full Article

Sun Pharmaceutical Industries And Unit Enter Settlements With Plaintiffs In Modafinil Antitrust Litigation
Monday, 26 Nov 2018 

Nov 26 (Reuters) - Sun Pharmaceutical Industries Ltd ::CO AND UNIT ENTERED SETTLEMENTS WITH CERTAIN PLAINTIFFS IN IN RE MODAFINIL ANTITRUST LITIGATION.SETTLEMENTS EXTEND TO ALL CLAIMS BROUGHT BY DIRECT PURCHASER PLAINTIFFS.TERMS OF SETTLEMENTS ARE CONFIDENTIAL.  Full Article

Sun Pharma Says Almirall Gets European Commission Approval For Ilumetri
Tuesday, 18 Sep 2018 

Sept 18 (Reuters) - Sun Pharmaceutical Industries Ltd ::SUN PHARMACEUTICAL INDUSTRIES LTD - ALMIRALL GETS EUROPEAN COMMISSION APPROVAL FOR ILUMETRI.  Full Article

Sun Pharmaceutical Industries Says USFDA Conducting Inspection Of Mohali Facilty
Tuesday, 11 Sep 2018 

Sept 11 (Reuters) - Sun Pharmaceutical Industries Ltd ::CLARIFIES ON NEWS ITEM, "SUN PHARMA'S MOHALI PLANT ON FDA RADAR".SUN PHARMACEUTICAL INDUSTRIES LTD <<>> - US FDA IS CONDUCTING AN INSPECTION OF SUN PHARMACEUTICAL INDUSTRIES'S MOHALI FACILITY .SUN PHARMACEUTICAL INDUSTRIES LTD <<>> - INSPECTION STARTED ON SEPTEMBER 10 AND IS ONGOING.  Full Article

Sun Pharmaceutical Industries Declares Interim Preference Dividend
Monday, 13 Aug 2018 

Aug 13 (Reuters) - Sun Pharmaceutical Industries Ltd ::SAYS DECLARES INTERIM PREFERENCE DIVIDEND OF 10 RUPEES/PREFERENCE SHARE.  Full Article

UPDATE 1-India's Sun Pharma Q3 profit jumps four-fold on strong U.S. show

Feb 12 India's largest drugmaker by market value Sun Pharmaceutical Industries Ltd posted a nearly four-fold jump in quarterly profit on Tuesday, breezing past estimates on strong sales in the U.S. market.